Abbott announced today that the U.S. Food and Drug Administration has approved the company’s Absorb bioresorbable heart stent, making the first-of-its-kind medical device commercially available to treat people with coronary artery disease in the United States.
Absorb is the only fully dissolving stent approved for the treatment of coronary artery disease, which affects 15 million people in the United States and remains a leading cause of death worldwide, despite decades of therapeutic advances. While stents are traditionally made of metal, Abbott’s Absorb stent is made of a naturally dissolving material, similar to dissolving sutures. Absorb disappears completely in approximately three years, after it has done its job of keeping a clogged artery open and promoting healing of the treated artery segment. By contrast, metal stents are permanent implants that restrict vessel motion for the life of the person treated.
To view the multimedia release go to:
http://www.multivu.com/players/English/7826651-abbott-fda-approval-stent/
Cision, a leading global media intelligence and communications solution provider and portfolio company of GTCR, announced that Kevin Akeroyd has been named global chief executive officer (CEO), effective today. Akeroyd succeeds Peter Granat, who established the company’s position as a global public relations and marketing cloud leader, and will transition to chairman of the Cision Board of Directors.
Akeroyd has more than 25 years of experience in reshaping modern digital, social and mobile marketing globally. Most recently he was general manager and senior vice president at Oracle Marketing Cloud where he orchestrated and executed the industry’s most prolific acquisition strategy, including Marketing Automation, Omni-Channel Campaign Management, Web Personalization, Content Marketing, DMP, Mobile Marketing, Data, and X-Device Orchestration. Under Akeroyd’s leadership, Oracle went from a non-entity to the #2 player in the entire industry in under three years, growing the business in 29 countries globally, and boasting the highest organic growth rate of all the major Marketing Cloud providers rate three years running. Integrating the solutions and the go-to-market, Akeroyd and Oracle created the Enterprise Marketing Platform category and have led it from the onset.
To view the multimedia release go to:
http://www.multivu.com/players/English/7896951-cision-kevin-akeroyd-new-global-ceo/
Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, announces today it has received U.S. Food and Drug Administration (FDA) approval for its newest innovative hearing loss solution, Kanso.
The Kanso Sound Processor provides a distinct new way for cochlear implant users to hear. Unlike most hearing aids and current cochlear implant sound processors that are worn on the ear, Kanso is a small, off-the-ear hearing device that provides a more discreet hearing solution and delivers the same hearing experience as a behind-the-ear sound processor.
The name Kanso is a Japanese word for ‘simplicity,’ and it was selected in recognition of Kanso’s all-in-one design. The Kanso Sound Processor features a single on/off button with no cables so it is easy to use. It is worn on the user’s head with nothing behind the ear, adding greater comfort for those with glasses, and it can be easily hidden under or blended within a user’s hair.
To view the multimedia release go to:
http://www.multivu.com/players/English/7658352-cochlear-kanso-fda-approval/
SunCulture Solar Inc. announces the launch of SolPad™, a new series of disruptive energy products designed to be the most advanced integrated-home or off-grid solar energy products in the world.
The SolPad’s integrated solar panel combines multiple patented technologies into a single beautiful device, including breakthrough battery storage, an innovative inverter system and intelligent software that engages and interacts with the user, giving them an unparalleled personal energy experience that gamifies energy distribution, delivery and usage.
SolPad is truly the world’s first fully integrated solar energy solution created for the modern smart home and sustainably minded global citizen.
To view the multimedia release go to:
http://www.multivu.com/players/English/7930451-sunculture-solar-solpad-energy/
University of St. Augustine for Health Sciences (USAHS), a leading graduate institution that emphasizes health and rehabilitative sciences education through innovative classroom education, is pleased to announce the installation of SafeGait 360° Balance and Mobility Trainer® on its Austin, Texas campus. The device, which was designed in collaboration with experts in physical therapy (PT) and occupational therapy (OT), works to mitigate the risk of injury from falls, protecting both the patient and therapist. In addition, SafeGait 360°’s dynamic fall protection (DFP) distinguishes between a patient’s intentional downward movement and when a patient is actually falling, which allows therapists to easily modify fall protection sensitivity to accommodate and challenge patients at varying stages of independence.
USAHS is one of the first higher education institutions in the nation to install this innovative body-weight support and fall protection system. In addition to conducting ground breaking research with patients and students, faculty members with extensive experience in body-weight treatments aim to open a clinic which will provide new treatment options to patients in the Austin community, and will begin seeing patients in October of this year.
To view the multimedia release go to:
http://www.multivu.com/players/English/7743851-usahs-safegait-360-physical-therapy/
As called for in the President’s Cybersecurity National Action Plan, the White House, the National Cyber Security Alliance (NCSA) and more than 35 companies and NGOs today announced a new internet safety and security campaign, “Lock Down Your Login,” to empower Americans to better protect their online accounts. The goal is to encourage a move beyond usernames and passwords to a widespread adoption of strong authentication for key online accounts. The majority of Americans (72 percent) believe their accounts are secure with just usernames and passwords. Usernames and passwords simply are not enough; hackers and cybercriminals continue to evolve their attack techniques, and users must improve their security to better protect their accounts.
The campaign is launching at a time when Americans are more connected than ever: 73 percent go online daily, and one in five are constantly connected. Coupled with increased connectivity are high levels of concern about identity theft, device security and risks such as phishing. In fact, a recent NCSA/Microsoft study found that preventing identity theft is the top online safety topic that both U.S. adults and teens (ages 13-17) would like to learn more about. Additionally, teens reported that unauthorized account access is their top online safety concern. Although Americans consistently express high levels of concern about identity theft, device security and risks such as phishing, many are either not aware or not using widely available, simple technologies to better secure their online accounts. Americans expect the cybersecurity community to help solve the problem. In another study, 78 percent of Americans reported they strongly or somewhat agree that government, industry and other stakeholders should work to find new ways of securing accounts beyond the password.
To view the multimedia release go to:
http://www.multivu.com/players/English/7934951-ncsa-lock-down-your-login-cyber-security/
Ascensia Diabetes Care today announced the availability of the CONTOUR®NEXT ONE blood glucose monitoring system (BGMS) in the United Kingdom, one of the next steps in the evolution of self-monitoring of blood glucose. As part of the system, the CONTOUR®NEXT ONE meter and CONTOUR®DIABETES app seamlessly connect, which makes capturing blood glucose results effortless for people with diabetes. The system enables patterns and trends to be revealed that can help people understand their diabetes, and may help to improve diabetes management.
The system features an easy-to-use wireless-enabled smart meter that links to a smart mobile device via Bluetooth® connectivity. The CONTOUR®NEXT ONE meter gives immediate feedback and also seamlessly connects to the CONTOUR®DIABETES app, which collects, stores and analyses patient blood glucose results received from the meter. The app combines these results with other data recorded by the user, to provide detailed information about their condition that can help them understand how their everyday lives may impact their blood glucose readings, including alerts for critical high or critical low readings. Through the app, meter users can also share with their healthcare professional the reports of their blood glucose results and patterns, either in advance or on the day of their appointment, helping to create more informed discussions.
To view the multimedia release go to:
http://www.multivu.com/players/uk/7954951-contour-next-one-bgms-ascensia/
The National Center for Missing & Exploited Children® and EMCOR Group, Inc.® (NYSE: EME), today announced the launch of Safety Central, a free child safety app available for Apple and Android devices. The app is designed to help parents and guardians protect their families and act quickly should their child go missing.
“Timing is critical when a child is missing and Safety Central lets parents provide the tools that law enforcement needs to start the search with just the touch of a button,” said John Walsh, NCMEC co-founder and host of CNN’s “The Hunt.” “This may be the most important App you’ll have on your device.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7925051-ncmec-emcor-safety-central-app/
LivaNova PLC (NASDAQ:LIVN; LSE: LIVN) (“LivaNova” or the “Company”), a market-leading medical technology and innovation company, today recognizes that more than one million people in the United States with drug-resistant epilepsy continue to be treated unsuccessfully with drugs, despite the proven effectiveness of non-drug treatment options. LivaNova’s VNS Therapy®, for example, is a medical device treatment specifically designed for people with drug-resistant epilepsy that is already used by more than 85,000 people around the world.
One in three people with epilepsy has the type that is not well controlled with drugs, called drug-resistant epilepsy. For those people, prescribing more medicine is usually not the most effective option. In fact, research shows that if you haven’t found seizure freedom after your first two drugs, there is a 95 percent chance that no drug or combination of drugs will result in seizure freedom.
“Despite what we know about drug-resistant epilepsy, the majority of people affected by this condition will continue to be prescribed additional medications instead of being evaluated for surgery or seen in a specialized epilepsy facility,” said Jason Richey, president of LivaNova’s U.S. Region and general manager of the Neuromodulation Business Franchise. “This treatment gap means over one million individuals in the U.S. with undertreated epilepsy remain at risk for dangerous side effects of continued seizures, including injury, depression, memory issues and death.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7966451-livanova-vns-therapy-epilepsy/
Carnival Corporation & plc (NYSE/LSE: CCL; NYSE: CUK), the world's largest leisure travel company with 10 global cruise line brands, today announced it has developed the world’s first interactive guest experience platform capable of transforming vacation travel into a highly personalized and elevated level of customized service for millions of guests.
The company unveiled the Ocean Medallion™, a first-of-its-kind wearable device that enables a personal concierge by bridging the physical and digital worlds to deliver a new level of personalized service not previously considered possible -- including sophisticated wayfinding, food and beverage on demand, an array of interactive gaming, personalized entertainment experiences and more. The quarter-sized, 1.8-ounce disc can be accessorized with jewelry, clips, key chains and bands or simply carried in a pocket or pocketbook.
To view the multimedia release go to:
http://www.multivu.com/players/English/8003551-carnival-corporation-ces-2017/
E-Alternative Solutions (EAS), a sister company to Jacksonville-based Swisher International, today launched a national advertising campaign for the Cue™ Vapor System (Cue) (patent pending), a breakthrough alternative to smoking. Cue is vaping made simple, providing fulfilling satisfaction in a premium-performance, stylish device that any adult smoker can operate with just the click of a cartridge and the push of a button. The closed system enables consumers to sidestep the complicated, and sometimes messy, process of using typical vaping devices. Cue is available for purchase online with appropriate age verification by visiting www.cuevapor.com.
To view the multimedia release go to:
https://www.multivu.com/players/English/8038851-e-alternative-solutions-eas-cue-vapor-system/
WebMD and Scripps Translational Science Institute (STSI) today announced a new investigative study designed to improve researchers’ and health care professionals’ understanding of what contributes to healthy pregnancies and positive pregnancy outcomes. The Healthy Pregnancy Study will use WebMD’s newly redesigned and enhanced Pregnancy app for iPhone. Incorporation of the Apple ResearchKit software framework will enable survey participants to eConsent, easily and anonymously answer questions, and share connected device data about their pregnancies with researchers for analysis.
“Pregnant women are one of the least studied populations in medical research,” said Dr. Eric Topol, director of STSI and editor-in-chief of Medscape. “The results of our Healthy Pregnancy Study -- on the foundation of an exceptionally popular smartphone app -- will ultimately provide expectant mothers, researchers, and health care professionals with new medical insights to avoid complications during pregnancy.”
To view the multimedia release go to:
https://www.multivu.com/players/English/7579757-webmd-stsi-healthy-pregnancy-study-app/
